This session covers: A working clinical vocabulary for peptide therapy structure, mechanism, and how peptides differ from hormones and proteins A clear breakdown of the July 2026 FDA PCAC review and what it means for compounded access Clinical profiles on BPC-157, TB-500, the Wolverine Stack, MOTS-c, and Sermorelin mechanism, dosing, contraindications, and monitoring A framework for confidently integrating peptides into your existing practice model Reserve your spot link in the comments below *The presenter speaks in an independent professional capacity
How much BAC water do I add to a 100mg GHK-Cu vial
The right choice depends on the injury type, individual health, biomarkers, and the specific bottleneck in healing
Insulin syringes work well for BPC-157 injection due to their small needle gauge (typically 29-31 gauge) and precise volume markings
Cells treated with AHK-Cu proliferated faster than untreated cells
Here is what Epithalon therapy costs at our Texas locations
